TARO 164.24 Taro Pharm Inds $TARO Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
TARO 164.24 Taro Pharm Inds $TARO Hit a 52 week high of 166.10 Closing the day 11/06/14 at 164.24 +1.00 +0.61% With a day low of 162.31 and a total volume of 84,091.

TARO Recent Posts: http://investorshangout.com/Taro-Pharmaceutic...ARO-67434/

TARO Taro Pharm Inds Recent Headline News

Taro to Announce Second Quarter Results on November 9, 2014
Business Wire - Wed Nov 05, 2:26PM CST
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2014, on Sunday, November 9, 2014.
TARO: 164.24 (+1.00)

Use The Relative Strength Line To Qualify A Breakout
at Investor's Business Daily - Wed Oct 29, 5:40PM CDT
Stock charts are a collection of facts and tools: price, volume, moving averages. All of them help you understand how a stock and its investors are responding to market input and supply and demand. One very helpful but often lesser-used tool is the...
TARO: 164.24 (+1.00)

Glaucoma Market Analysis 2014-2015 - API Manufacturers and Phase III Pipeline Assessment
M2 - Thu Oct 02, 4:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qn2l4v/glaucoma_market) has announced the addition of the "Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014" report to their offering. Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication. Key Topics Covered: - Indication Overview - Marketed Drugs Assessment - Marketed Details of Drugs by Application Type - Marketed Details of Drugs (NDA) by Marketing Status - Marketed Details of Drugs by Patent Expiration Timeline - The Active Pharmaceutical Ingredient (API) Manufacturers Assessment - The API Manufacturers by the United States Drug Master File (US DMF) Status - The API Manufacturers by the US DMF Status (Drug Specific) - The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs - The API Manufacturers by the US DMF Status (Drug Specific) - Drugs Market Data and Forecasted Sales Figures (2011-2015) - Marketed Drugs Information - Drugs Description - Route of Synthesis - Global Active Pharmaceutical Manufacturers - Approval Status - Patent and Exclusivity Details - Company Overview - Phase III Drugs Information - Phase III Drugs Description - The United States Drug Master Filings (US DMF) - Discontinued Drugs Information Companies Mentioned - Allergan, Inc. - Merck & Co., Inc. - Alcon, Inc. - Taro Pharmaceutical Industries Ltd. - Pharmacia & Upjohn, Inc. - Teva Pharmaceuticals USA, Inc. - Akorn, Inc. - Pfizer Inc. - Alcon Laboratories, Inc. - Bausch & Lomb Incorporated - JHP Pharmaceuticals, LLC - Mobius Therapeutics, LLC - American Regent, Inc. For more information visit http://www.researchandmarkets.com/research/qn...oma_market
AGN: 197.40 (+1.08), TARO: 164.24 (+1.00), AKRX: 37.88 (-3.80), PFE: 30.04 (unch), MRK: 59.26 (-0.31)

Taro Provides Results for Quarter Ended June 2014
Business Wire - Thu Aug 07, 5:47PM CDT
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company" today provided unaudited financial results for the three month period ended June 30, 2014.
TARO: 164.24 (+1.00)

Taro to Announce Results for Quarter Ended June 30, 2014
Business Wire - Mon Aug 04, 4:05PM CDT
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2014 after market close on Thursday, August 7, 2014.
TARO: 164.24 (+1.00)

4 Stocks Spiking on Big Volume
at The Street - Thu Jul 31, 8:03AM CDT
Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
TARO: 164.24 (+1.00), PNRA: 167.29 (+2.00), EPAY: 25.00 (+0.66), EEFT: 54.19 (-0.45)

Israel's Market Appears Unfazed By Rising Conflict
at Investor's Business Daily - Tue Jul 22, 5:07PM CDT
The conflict between Israel and Palestinians caused the U.S. Federal Aviation Administration on Tuesday to temporarily ban American flights to and from Tel Aviv's Ben Gurion International Airport after a rocket landed near the facility. The airport...
PRGO: 152.49 (-6.01), CSTE: 59.81 (+0.76), EIS: 49.79 (+0.52), TARO: 164.24 (+1.00), ISRA: 30.94 (+0.16), TSEM: 10.32 (+0.17), TEVA: 58.72 (+0.93), MLNX: 44.37 (-0.07), CHKP: 74.51 (+0.62)

Taro Annual Report For Fiscal Year Ended March 31, 2014 on Form 20-F Available
Business Wire - Tue Jul 08, 6:42PM CDT
Taro Pharmaceutical Industries Ltd. (NYSE: TARO, "Taro" announced that its Annual Report for fiscal year ended March 31, 2014 on Form 20-F, filed with the Securities and Exchange Commission (the "SEC" , is available within the Investor Relations section of Taro's website at www.taro.com. Hard copies of the report may be ordered free of charge by sending requests to Taro Pharmaceuticals U.S.A., Inc., Three Skyline Drive, Hawthorne, NY 10532, attention: William J. Coote or via email to William.Coote@Taro.com.
TARO: 164.24 (+1.00)

NYSE stocks posting largest percentage increases
AP - Fri Jun 27, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
BTH: 8.96 (+0.26), NWHM: 15.02 (+0.19), SFE: 20.04 (+0.09), TRR: 7.10 (+0.12), AZZ: 46.99 (-0.30), EGO: 5.25 (+0.24), TARO: 164.24 (+1.00), ELD.TO: 6.00 (+0.30), PKE: 26.17 (+0.32), MTW: 20.97 (+0.44), GNI: 20.55 (+0.60)

Novo, Other Medicals Display Healthy Action
at Investor's Business Daily - Thu Jun 26, 5:41PM CDT
Leaders in buy range could get tougher to find as the market uptrend continues and stocks break out to new highs. But a raft of medical plays in today's Your Weekly Review are showing fairly healthy action as they work on bases or move near buy...
ACT: 250.38 (+2.47), MYGN: 34.78 (+0.17), NVO: 43.79 (-0.20), TARO: 164.24 (+1.00), SLXP: 138.55 (-0.95), ILMN: 189.87 (+3.50), MYL: 53.50 (+0.03)

3 Stocks Boosting The Health Care Sector Higher
at The Street - Thu Jun 26, 12:02PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
TARO: 164.24 (+1.00), ABBV: 62.71 (+0.17), FMS: 36.22 (-0.28)

Why I'm Avoiding Taro Pharmaceuticals
Nathaniel Calloway, The Motley Fool - Motley Fool - Fri Jun 13, 4:14PM CDT
Based purely on financial metrics, Taro Pharmaceuticals   looks like a great investment. Taro is Israeli generic and branded pharmaceutical maker focused primarily on dermatology and skincare that has been undergoing unprecedented growth in the...
TARO: 164.24 (+1.00)

Taro Announces Results of Its Extraordinary General Meeting of Shareholders
Business Wire - Thu Mar 27, 4:05PM CDT
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company" announced that the Company held an extraordinary general meeting of shareholders today, March 27, 2014, at 14 Hakitor Street, Haifa Bay 26110, Israel (the "Extraordinary General Meeting" . IVS Associates, Inc., a leading provider of independent election services, independently tabulated and certified the voting results of the Extraordinary General Meeting.
TARO: 164.24 (+1.00)

Taro Pharmaceutical Industries Ltd. (TARO) Stock Research Links

TARO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 258

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 334

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 333

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 282

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 546

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 461

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 466

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 289

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 411

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 335

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading

Top 5 Most Recently Viewed Articles

Apple Inc. Announces Record Q4 Results and Product Launches

Updated Category News Views 236

Apple Achieves Remarkable Fourth Quarter Results Apple Inc. has announced its financial performance for the fourth quarter of its fiscal year 2024, showcasing stellar results that reflect the company's growth and expansion in the tech industry. The tech giant reported quarterly revenue hitting a staggering $94.9 billion, which represents a 6% increase compared to the...

Continue Reading
China-Russia Culture Fair Boosts Jiamusi, Heilongjiang

Updated Category News Views 100

Jiamusi: A Cultural Crossroad in Northeast China Imagine this: Jiamusi, nestled in the embrace of Heilongjiang Province, stepping into the spotlight as it co-hosts the 16th China-Russia culture fair. This northeast city isn't just another dot on the map. It's gearing up to be a hub of cultural buzz, packed with ties that go beyond borders. From July through September,...

Continue Reading
Unlocking Sustainability in Broadband Using Existing Networks

Updated Category News Views 176

Unlocking Sustainability in Broadband Using Existing Networks LUND, Sweden — InCoax Networks has introduced a groundbreaking whitepaper addressing the modernization of broadband infrastructure in multi-dwelling units (MDUs). This initiative is not only cost-effective but also significantly improves the environmental impact associated with deploying broadband services....

Continue Reading
Interlink Electronics Secures NASA Grant for Air Quality Solutions

Updated Category News Views 174

Interlink Electronics Receives Significant Funding from NASA Recognizes Company's leading position in gas sensor research and commercialization Interlink Electronics, Inc. (NASDAQ: LINK), a premier provider of innovative sensors and electronic solutions, has received a significant boost with a $150,000 award from NASA. This funding is designated for the development of...

Continue Reading
Burford Capital Set to Reveal 3Q24 Financial Insights Soon

Updated Category News Views 154

Burford Capital Set to Release 3Q24 Financial Results Burford Capital Limited, renowned for its leadership in finance and asset management focused on legal services, has announced the date for its financial results. The firm is poised to share critical insights regarding its performance for the three and nine months ending September 30, 2024. Details of the Financial...

Continue Reading